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ABNORMAL antigens have been demonstrated by immunodiffusion methods in
both the soluble cytoplasmic protein (cell sap) and microsome fractions ofprimary,
4-dimethylaminoazobenzene (DMAB)-induced rat hepatomas which could not be
detected in normal or carcinogen treated liver (Baldwin, 1965). Comparable
with these observations are the findings of Abelev and Avenirova (1960) showing
thepresence ofabnormal antigens ino-aminoazotoluene-induced mouse hepatomas.
Similarly, Hirai et al. (1963) demonstrated new antigens in a soluble protein
fraction from a transplanted rat hepatoma originally induced with DMAB and
Deckers (1964) identified abnormal microsomal antigens.
Further, unequivocal evidence of tumour-specific antigens in DMAB-induced
rat hepatomas has been provided by the demonstration that resistance can be
evoked against tumour transplanted into isogeneic hosts (Baldwin and Barker,
1965). These studies also indicated that each tumour possessed an individual
antigenic specificity since induction of resistance to one tumour did not modify
the growth ofother DMAB-induced hepatomas.
In the previous study (Baldwin, 1965) heterologous antisera were produced
against sub-cellular fractions from pools of several primary hepatomas thereby
excluding the possibility of examining the specific antigenicities of individual
tumours. Accordingly, a more detailed study of the abnormal antigens demon-
strable by immunodiffusion methods in individual DMAB-induced hepatomas has
been undertaken. For this purpose, the antigenic composition of sub-cellular
fractions of two transplanted hepatomas (D8 and D14) have been compared with
each other and with a range ofother transplanted hepatomas. Furthermore, the
tumour specificity of the abnormal antigens demonstrable in these two tumours
has been more closely investigated by comparison ofthe cross-reactions with sub-
cellular fractions ofa number ofnormal tissues and foetal rat serum.
MATERIALS AND METHODS
Rats.-Rats of an inbred Wistar strain were used for all tests. These were
maintained on a standard cubed diet (MRC41B) or a low protein diet containing
carcinogen with water ad libitum.
Induction ofTumours
Hepatomas were induced by feeding 4-dimethylaminoazobenzene (DMAB) at a
level of 0*06 per cent in an unpolished rice-carrot diet for 3 months followed by
continuous feeding on the basal diet (Baldwin, 1964). One tumour, a hepato-
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months after initial exposure to DMAB. The tumour was passaged by subcu-
taneous implantation into isogeneic male rats and used in the present studies
between the eighth and eighteenth generation 'of transfer. The second tumour
studied in detail (D14), also a hepatocellular carcinoma, arose in a male rat 5
months after the start of carcinogen treatment. This tumour was similarly
passaged by subcutaneous implantation and was used between the fourth and
eighth generation of transfer.
Other hepatomas, originally induced with DMAB, were similarly passaged
either by subcutaneous or intraperitoneal inoculation into isogeneic rats of the
same sex as the tumour donor and were generally used within the first and ninth
generation of transfer.
Preparation of tissue fractions
Healthy, non-necrotic tumour tissue and various normal rat tissues other than
liver and kidney were thoroughly washed in ice cold 0 15 M NaCl and then 0 44 M
sucrose before mincing and homogenisation in 0*44 M sucrose (4 ml./g. wet weight
tissue). Liver and kidney were thoroughly perfused in situ with ice cold 0*15 M
NaCl and 0 44 M sucrose before homogenisation in 0 44 M sucrose (2 ml./g. wet
weight of tissue). Tissue homogenates were then subjected to differential
centrifugation as previously described (Baldwin, 1965) to separate microsome and
soluble cell sap fractions. The protein content oftissue fractions was determined
using the method of Lowry et at. (1951). Fractions were either used immedi-
ately after isolation or were stored at -20° C. until required.
Preparation ofantisera
Sub-cellular fractions from tumours D8 and D14 were freshly prepared for
immunisation. The cell sap fractions were used in 0 44 M sucrose and contained
between 9 to 14 mg. protein/ml. The microsome fractions were resuspended
in 0-25 M sucrose (0.25 ml./g. tumour) and contained 6-9 mg. protein/ml.
Adult albino rabbits were injected intramuscularly with tumour fractions
(1 ml.) blended with equal volumes of Freund's complete adjuvant (Difco
Laboratories), the dose being divided between each hind leg. Inoculations were
administered at 3-weekly intervals, each rabbit receiving a total of 5 injections.
Rabbits were bled 2 weeks after the final injection and sera collected. Merthiolate
was added to a concentration of0.01 per cent and antisera were stored at -20° C.
Immunochemicalprocedures
Double diffusion analyses were carried out in 1 per cent agar gel in buffered
saline (0-15 M NaCl, 0-01 M Na phosphate buffer, pH 7.4) as previously described.
Cell sap fractions were tested directly in 0-44 M sucrose whilst microsome fractions
were solubilised in 0 4 per cent sodium deoxycholate in 0-25 M sucrose (Baldwin,
1964).
Absorption procedures
Rabbit antisera were absorbed with normal rat serum (0-1-0-3 ml./ml.
antiserum) and the appropriate normal liver fraction (1-2.5 mg. protein/ml.).
After mixing, antisera were kept at 20 C. for 4 days and then precipitates were
removed by centrifugation (3500 g., 30 minutes).
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Rat serum
Blood was collected from adult rats (4-12 months of age) by cardiac puncture
under ether anaesthesia and from new born rats (less than 24 hours post-parturi-
tion) by exposing the heart, puncturing it and aspirating the thoracic cavity.
Blood was allowed to clot at room temperature and the serum stored at -20° C.
RESULTS
Preliminary investigations were carried out with rabbit antisera against cell
sap and microsome fractions of tumours D8 and D14 to ascertain whether or not
abnormal antigens could be demonstrated. Also, the stability of these antigens
throughout the transplant generations of tumour used in these studies was ex-
amined. For this purpose, the antisera were absorbed with the corresponding
normal liver sub-cellular fractions and normal rat serum in order to simplify the
immunodiffusion reactions.
Immunodiffusion reactions of D8 cell sap with antiserum against this fraction
demonstrated three abnormal tumour antigens which did not cross-react with
normal liver cell sap or normal rat serum (Fig. 1). Furthermore, the reaction
patterns were qualitatively similar with cell fractions from tumour between the
ninth and seventeenth generations of transfer indicating that these antigens were
stable components of the tumour. Likewise, interactions of D14 cell sap with
antiserum against this fraction demonstrated an abnormal antigen which was
absent from normal liver or normal rat serum (Fig. 2). This antigen was common
to all transplant generations of the tumour used in these studies.
Similar studies with deoxycholate solubilised microsome fractions of tumours
D8 and D14 revealed the presence ofabnormal antigens that could not be detected
in normal liver microsomes or adult rat serum. Examination of fractions
prepared from several generations of transfer of each tumour showed that the
abnormal microsome antigens were stable characteristics of each tumour (Fig. 3).
Specificity of the abnormal antigens in D8 andl D14 tumours
In order to determine whether the abnormal cell sap antigens in tumour D8
were tumour specific, antisera against this fraction as well as being absorbed with
normal liver and serum were absorbed with D14 cell sap (1.2 mg./ml.). The
absorbed antiserum was then cross-reacted with D8 and D14 cell sap fractions
and as shown in Fig. 4, the three abnormal D8 antigens (numbered 1 to 3 starting
from the antigen well) were still demonstrable, but these showed no cross-reaction
with D14 components. Similarly pre-absorption of anti-D14 cell sap antiserum
with D8 cell sap (1.2 mg./ml.) demonstrated that the D14 antigen was not present
in D8.
In contrast, the abnormal microsomal antigens demonstrable in tumours D8
and D14 were found to have common specificities. This is illustrated in Fig. 3
which shows the cross-reactions ofmicrosome fractions oftumours D8 and D14 at
various generations of transfer with suitably absorbed antiserum against D14
microsomes. Whilst four antigens (numbered 1 to 4 from the antigen well) in
tumour D14 microsomes did not cross-react with either normal liver or serum, each
of these antigens was also detectable in tumour D8. Similarly using antiserum
against D8 microsomes, allowed the demonstration of four abnormal antigens but
these cross-reacted with D14 microsomes.
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The specificity of the three abnormal cell sap antigens of D8 and the one
present in D14 were further investigated in comparative studies with a greater
range of transplanted rat hepatomas. Each of these tumours was originally
induced with DMAB and the tumours passaged in isogeneic hosts. When the
antigenic composition of cell sap fractions from these tumours was compared with
that of D8 and D14 using antisera against the two latter tumours, it was found
that cross-reactions could be obtained with each ofthe abnormal D8 and D14 cell
sap antigens (Table I). A typical example illustrated in Fig. 5 shows the cross-
reaction of D23 and D14 cell sap fractions with anti D14 cell sap antiserum.
TABLE I.-Distribution ofD8 and D14 Abnormal Cell Sap Antigens in
4-Dimethylaminoazobenzene-induceed Rat Hepatomas
Antigens demonstrated
A_
A
D8
A ^ 5 D14
Tumour Transplant generation 1 2 3 1
D8 . 8-18 .+ + + -
D14 . 4-8 . - - +
D1O . 1 . - - - -
D20 . 1 .- - + -
D23 5 .+ - - +
D25 . 12 - - + -
D30 . 4 *- - - -
D31 4 .- - + -
D32 . 2 .+ + - -
D33 . 9 .+ + - -
D37 . 1 .- - + -
D38 . 1 .- - + -
D39 . 9 *- - +
D41 . 5 . - - - -
D42 4 .- - - +
Tumour specificity ofthe abnormal antigens
Whilst the abnormal antigens demonstrable in sub-cellular fractions of
tumours D8 and D14 were not detectable in normal rat liver, the possibility
remained that these antigens were not tumour-specific but may be found in other
normal rat tissues. In order to investigate the tumour specificity ofthe abnormal
antigens, their cross-reactions with sub-cellular fractions of a variety of normal
adult rat tissues were examined. In addition, cross-reaction with embryonic
rat serum was examined since Abelev et al. (1963) have shown that an abnormal
microsomal antigen in o-aminoazotoluene-induced mouse hepatomas cross-reacted
with an embryonal serum a-globulin component.
The results, summarised in Table II, indicate that the abnormal cell sap
antigen demonstrated in D14 cross-reacted with embryonic rat-serum but not
with adult serum. This is illustrated in Fig. 5. In contrast, none of the 3 cell
sap antigens of D8 showed any cross-reaction with either adult or embryonic rat
serum. However, 1 ofthese antigens (D8-1) could be detected in cell sap fractions
prepared from either normal rat lung or spleen (Fig. 6).
Likewise, of the 4 common microsomal antigens demonstrable in tumours D8
and D14, one (D8/14-1) was detected in rat lung, another (D8/14-2) in kidney
whilst a third D8/14-3) could be found in both spleen and lung. The fourth
antigen (D8/14-4) could not be detected in any ofthe normal tissues examined.
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TABLE II.-Distributtion of D8 and D14 Tumour Antigens in Normal Rat Tissues
Antigens demonstrated
Cell sap
A Microsomes
D8 D8/14
____A D14 ,
A
Tissue 1 2 3 1 1 2 3 4
Liver .
Adult rat serum
New born rat serum . -
Kidney . . - - - - +
Lung . . . . + - - - + - + -
Spleen. . . . + - - - - - + -
Brain
EXPLANATION OF PLATES
FiG. 1.-Agar gel precipitation reactions of tissue cell sap fractions with antiserum against
tumour D8 cell sap.
D8TCS-Tumour D8 cell sap.
NLiCS-Normal liver cell sap.
NRS-Normal rat serum.
Anti-D8TCS abs-Rabbit antiserum against tumour D8 cell sap absorbed with normal
liver cell sap (2.5 mg. protein/ml. antiserum) and normal rat serum (0.1 ml./ml. antiserum).
FIG. 2.-Agar gel precipitation reactions of tissue cell sap fractions with antiserum against
tumour D14 cell sap.
D14/4-7-cell sap fractions from fourth to seventh generation of tumour D14 transfer.
NLi-Normal liver cell sap.
NRS-Normal rat serum.
Anti-D14-Rabbit antiserum against tumour D14 cell sap absorbed with normal liver cell
sap (5 mg. protein/ml. antiserum) and normal rat serum (0-3 ml./ml. antiserum).
FIG. 3.-Agar gel precipitation reactions of deoxycholate solubilised microsomal fractions of
tissue and rabbit antiserum against tumour D14 microsomes.
D8/13 and 17-Microsomal fractions from thirteenth and seventeenth generation of trans-
plant of tumour D8.
D14/6 and 7-Microsomal fractions from sixth and seventh generation of transplant of
tumour D14.
NLi-Normal liver microsomes.
Anti-D14 Rabbit antiserum against tumour D14 microsomes absorbed with normal liver
microsomes (1.2 mg. protein/ml. antiserum) and normal rat serum (0.2 ml./ml. antiserum).
FIG. 4.-Agar gel precipitation reactions of tumour D8 and D14 cell sap fractions.
D8-Tumour D8 cell sap.
D14-Tumour D14 cell sap.
Anti-D8 Rabbit antiserum against tumour D8 cell sap absorbed with normal liver cell sap
(2.5 mg. protein/ml. antiserum), normal rat serum (0-1 ml./ml. antiserum) and tumour
D14 cell sap (1.2 mg. protein/ml. antiserum).
Anti-Dl4-Rabbit antiserum against tumour D14 cell sap absorbed with normal liver cell
sap (2.5 mg. protein/ml. antiserum), normal rat serum (0.1 ml./ml. antiserum) and tumour
D8 cell sap (1.8 mg. protein/ml. antiserum).
FIG. 5.-Agar gel precipitation reactions between tumour cell sap fractions and antiserum
against tumour D14 cell sap.
D14-Tumour D14 cell sap.
D23-Tumour D23 cell sap.
NBRS-New born rat serum.
Anti-D14 Rabbit antiserum against tumour D14 cell sap absorbed with normal liver cell
sap (2-5 mg. protein/ml. antiserum) and normal rat serum (0-1 ml./ml. antiserum).
FIG. 6.-Agargel precipitation reactions between tissue cell sap fractions and antiserum against
tumour D8 cell sap.
D8TCS-Tumour D8 cell sap.
Spleen CS spleen cell sap.
Lung CS-Lung cell sap.
Anti-D8 TCS abs-Rabbit antiserum against tumour D8 cell sap absorbed with normal liver
cell sap (2-5 mg. protein/ml. antiserum) and normal rat serum (0-1 ml./ml. antiserum).
342Vol. XXI, No. 2. BRITISH JOURNAL OF CANCEn.
2
3
Baldwin and Barker.
IBRITISH JOURNAAL OF CANCER.
5
:::....... . al:!..... ..... .,=lfl..... ..i.:.
6
Baldwin and Barker.
VOl. XXI, NO. 2.ANTIGENIC COMPOSITION OF RAT HEPATOMAS
DISCUSSION
These results demonstrate antigens in both the cell sap and microsomal
fractions of transplanted rat hepatomas originally induced with 4-dimethyl-
aminoazobenzene (DMAB) which are not detectable in normal rat liver or serum.
As previously shown with primary hepatomas (Baldwin, 1965) the pattern of
abnormal antigens is complex, tumour D8 exhibiting three, and tumour D14 one,
cell sap antigens whilst both tumours contain four abnormal microsomal antigens.
Furthermore, these antigens appear to be stable characteristics of each tumour,
since no qualitative differences were detected during the limited period of tumour
transplantation used in these studies.
The multiplicity of abnormal antigens detected contrasts with other observa-
tions (Deckers and Maisin, 1961; Abelev and Avenirova, 1960; Hirai et al., 1963)
where only a single new antigen was found in transplanted tumours induced with
aminoazo dyes. Variations in experimental methods andperhaps more particularly
differences in the potencies of antisera utilised may have contributed to these
differences. Additionally, however, most other studies have used long-trans-
planted tumours and it is likely that deletion of antigen may have occurred on
transplantation especially if there were isoantigenic differences between tumour
and host. Thus, for example, Baldwin and Barker (1967) and Guelstein and
Khramkova (1965) have shown that normal tissue antigens are deleted from experi-
mental hepatomas even after only a few generations oftransplantation in isogeneic
hosts.
Whilst the abnormal microsomal antigens detected were common to both
tumour D8 and D14, the new cell sap antigens ofthese two tumours were found to
differ. Comparable differences in the antigenic composition of 2-acetylamino-
fluorene-induced rat hepatomas can be implied from demonstrations of specific
immunofluorescent staining by rabbit antisera prepared against individual
tumours (Hiramoto, Jurand, Bernecky and Pressman, 1963). However each of
the cell sap antigens of D8 and D14 were detectable in other hepatomas induced
by DMAB, occurring in various combinations in individual tumours (Table I).
It is unlikely therefore that these antigens can be correlated with the tumour
specific transplantation antigens demonstrated by the induction of resistance to
hepatoma transplanted into isogeneic rats, since these have been shown to be
individually distinct (Baldwin and Barker, 1965). This is further supported by
the finding that pre-treatment of rats with either cell sap or microsome fractions
of a transplanted hepatoma (D23) was without influence on the subsequent
development of a challenge with the same tumour (unpublished observations).
Whilst the abnormal cell sap and microsomal antigens demonstrable in tumours
D8 and D14 could not be detected in normal rat liver or serum, one D8 cell sap
antigen was found in rat lung and spleen and three ofthe four microsomal antigens
were identifiable in other normal rat tissues. Furthermore, the D14 cell sap
antigen cross-reacted with a component of new born or foetal rat serum. None
of the other abnormal tumour antigens could be found in normal tissues but this
does not prove unequivocally that they are tumour specific since the possibility
cannot be excluded that they occur in other normal or embryonic tissues. Whilst
these observations further indicate that the antigens demonstrable by immuno-
diffusion methods are not related to the tumour specific transplantation antigens,
they are nevertheless of considerable interest in that they probably reflect pro-
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cesses of dedifferentiation of liver during neoplastic transformation. Thus, for
example, the cross-reaction of the D14 cell sap antigen, which was also detected
in two out of thirteen other hepatomas, with an embryonic serum component
compares with the finding ofan embryonic serum a globulin in o-aminoazotoluene-
induced mouse hepatomas (Abelev et al., 1963). Also an embryonic a globulin has
been detected in the serum ofa patient with carcinoma ofliver (Kithier, Houstek
Masopust and Radl, 1966). The finding that several of the antigens in DMAB-
induced hepatomas, whilst absent from liver, could be found in othernormal tissues
compares with the observation by Day (1965) that antisera against microsome
fractions of 2-acetylaminofluorene-induced rat hepatomas could be shown by
fluorescence microscopy to cross-react with rat kidney. Gold and Freedman
(1965) also showed that an antigen demonstrable in human colonic carcinoma,
whilst not detectable in normal adult tissues, could be found in a number of
human embryonic tissues and was thus termed a carcinoembryonic antigen.
It would thus appear that neoplastic transformation induced in rat liver by
DMAB is accompanied by a loss of antigens characteristic of the tissue of origin
(Baldwin, 1964) together with the appearance of new antigens, some of which are
demonstrable in other adult or embryonic tissues and others which are specific
for the individual tumour (Baldwin and Barker, 1965). It still remains to be
established whether these antigenic changes contribute to the functioning of the
tumour cell or reflect significant causative processes during carcinogenesis.
SUMMARY
1. Abnormal cell sap and microsomal antigens, not present in normal liver or
adult rat serum, have been demonstrated using immunodiffusion methods in two
rat hepatomas induced with 4-dimethylaminoazobenzene (DMAB). The micro-
somal antigens were common to both tumours whilst those in the cell sap differed.
These cell sap antigens were all detectable however in differing combinations in
other DMAB-induced hepatomas thus indicating that they were not tumour
specific.
2. Certain ofthe new tumour cell sap and microsomal antigens could be detected
in normal rat tissues other than liver or in foetal rat serum and these are considered
to be a manifestation ofprocesses ofdedifferentiation during carcinogenesis.
This work was supported by a block grant from the British Empire Cancer
Campaign for Research.
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